Int J Aging. 2023;1:e14.
doi: 10.34172/ija.2023.e14
Letter to Editor
Artificial Intelligence in Dementia Diagnosis: Past, Present, and Future
Mahdi Zarei 1, *
, Milad Asheghi 2
, Maryam Zarei 3 
Author information:
1Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3Khajeh Nasir Toosi University of Technology, Tehran, Iran
Dear Editor,
Dementia can be regarded as one of the biggest medical and health challenges in the last century. Paying attention to recent studies confirms this point. The age-standardized point prevalence of dementia was equal to 777.6 per 100 000 people in the Middle East region and North Africa in 2019, indicating a 3% growth compared to 1990. The point prevalence of the disease has grown during the last three decades,1 while the number of individuals affected by it is expected to reach 152 million worldwide by 2050.2 Dementia can be considered neurodegenerative changes in the brain accompanied by symptoms such as impairments in the process of memory, thought, language, functioning, and problem-solving ability.3 It can also disrupt patients’ daily functioning and lower their quality of life. Dementia contains several risk factors such as hypertension, obesity, diabetes, lack of physical activity, and alcohol consumption. It should be noted that in addition to the above factors, this category of disorder becomes more prevalent with age.2,4
Artificial intelligence and its algorithms, particularly machine learning (ML) have transformed medical service provision. Numerous studies have been conducted on using artificial intelligence in the fields of neuroimaging and its interpretation,5 cognitive assessment tests,6 movement tests,7 and speech and language tests8 to diagnose dementia disorders quickly and timely. Many diagnostic tests and modalities for this disease require the presence of trained and specialized staff and also spending a substantial amount of money and time for interpretation. Artificial intelligence can facilitate disease diagnosis, make healthcare service provision more effective with high quality, and make the use of limited financial resources more practical.9
Artificial intelligence can contribute to a wide range of diagnostic tests, which are shortly mentioned in the following.
A. Cognitive Tests
In addition to interpreting the final result, using artificial intelligence algorithms in cognitive tests can provide data regarding the participants’ behaviors during the test implementation, and it makes the early diagnosis of the disease possible by lowering costs and enhancing accessibility.2 By final measurement of working memory, visual memory, information processing time, cognitive recognition, and problem-solving ability, on the one hand, and evaluating the participants’ functioning during the implementation of the test, on the other hand, artificial intelligence-based cognitive tests based on ML algorithms such as support vector machine (SVM) can provide the basis for the timely diagnosis of dementia disorders with high sensitivity and specificity.6
B. Movement Tests
-
The use of ML algorithms, in addition to logistic and regression models, can help diagnose different dementia syndromes with high accuracy by evaluating the patient’s movement speed, movement rhythm, asymmetry, gait analysis, and variability.10
-
The use of the SVM algorithm by evaluating finger-tapping movements makes it possible to diagnose individuals with dementia with high accuracy.11
-
The evaluation of handwriting, graphic drawing, movement fluency features during the test implementation, pauses during writing, and differences in the letter size using artificial intelligence-based methods, in addition to obtaining the data from the patient history and physical examination, can diagnose the disease in the early stages with high accuracy.12
-
The evaluation of eye movements using logistic regression statistical models, SVM, and Naïve Bayes model has been suggested as a criterion for the early diagnosis of dementia in various studies.2 By investigating memory tests and eye fixating, a study extracted the data related to 13 eye movements, and finally, square regression, ridge regression, and Lasso regression were used for data categorization and disease diagnosis.13
C. Speech and Language Tests
In its early stages, dementia can influence language skills and be associated with aphasia, pauses in speaking, and a reduced range of words.14 The general principles of this group of tests include extracting language patterns and interpreting them in accordance with ML and deep learning (DL) algorithms. The language patterns used in these tests are generally divided into two categories: speech content and speech presentation. Another application of artificial intelligence in this category is testing the photo interpretation and its related conversation and interpreting the data using the ML algorithm, which can diagnose the disease in the early stages with relatively high accuracy.15
D. Using Artificial Intelligence in the Interpretation of Imaging Modalities
Magnetic resonance imaging, computerized tomography scan, and, in some cases, positron emission tomography scan play a crucial role in dementia diagnosis. ML algorithms (SVM, and particularly DL) play a significant role in the process of interpreting the data obtained from imaging. Using the above algorithms can increase the diagnosis accuracy and the possibility of timely diagnosis and also provide the basis for greater use of these modalities16 (Figure 1).
Figure 1.
Artificial Intelligence in Dementia Diagnosis. Note. AI: Artificial intelligence
Figure 1.
Artificial Intelligence in Dementia Diagnosis. Note. AI: Artificial intelligence
Ultimately, although some artificial intelligence-based modalities have not been widely used in clinical settings yet, we hope that with the expansion of artificial intelligence use, the diagnosis of this disease will be facilitated, and diagnostic accuracy will enhance. Moreover, due to lower costs and less need for the presence of an expert, the provision of these services is made possible in more regions of the world. Thus, given the increasing trend of using artificial intelligencein the diagnosis and treatment of neurological diseases, the need for doctors to get familiar with the application and how to use the above modalities is felt more than ever.
Acknowledgements
We would like to appreciate the cooperation of the Clinical Research Development Unit, Imam Reza General Hospital, Tabriz, Iran in conducting this research.
Funding
Not applicable.
Data availability statement
All data generated or analyzed during this study are included in this published article.
Ethical approval
Not applicable.
Consent for publication
Not applicable.
Conflict of interests
The authors declare no competing interests.
References
- Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M. The burden of Alzheimer’s disease and other types of dementia in the Middle East and North Africa region, 1990-2019. Age Ageing 2023; 52(3):afad042. doi: 10.1093/ageing/afad042 [Crossref] [ Google Scholar]
- Li R, Wang X, Lawler K, Garg S, Bai Q, Alty J. Applications of artificial intelligence to aid early detection of dementia: a scoping review on current capabilities and future directions. J Biomed Inform 2022; 127:104030. doi: 10.1016/j.jbi.2022.104030 [Crossref] [ Google Scholar]
- Spiegel D, Lewis-Fernández R, Lanius R, Vermetten E, Simeon D, Friedman M. Dissociative disorders in DSM-5. Annu Rev Clin Psychol 2013; 9:299-326. doi: 10.1146/annurev-clinpsy-050212-185531 [Crossref] [ Google Scholar]
- Chen JH, Lin KP, Chen YC. Risk factors for dementia. J Formos Med Assoc 2009; 108(10):754-64. doi: 10.1016/s0929-6646(09)60402-2 [Crossref] [ Google Scholar]
- Mathotaarachchi S, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T. Identifying incipient dementia individuals using machine learning and amyloid imaging. Neurobiol Aging 2017; 59:80-90. doi: 10.1016/j.neurobiolaging.2017.06.027 [Crossref] [ Google Scholar]
- Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL. Use of the CogState Brief Battery in the assessment of Alzheimer’s disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol 2012; 34(4):345-58. doi: 10.1080/13803395.2011.643227 [Crossref] [ Google Scholar]
- Beauchet O, Allali G, Annweiler C, Verghese J. Association of motoric cognitive risk syndrome with brain volumes: results from the GAIT study. J Gerontol A Biol Sci Med Sci 2016; 71(8):1081-8. doi: 10.1093/gerona/glw012 [Crossref] [ Google Scholar]
- Haider F, De La Fuente S, Luz S. An assessment of paralinguistic acoustic features for detection of Alzheimer’s dementia in spontaneous speech. IEEE J Sel Top Signal Process 2020; 14(2):272-81. doi: 10.1109/jstsp.2019.2955022 [Crossref] [ Google Scholar]
- Venugopalan J, Tong L, Hassanzadeh HR, Wang MD. Multimodal deep learning models for early detection of Alzheimer’s disease stage. Sci Rep 2021; 11(1):3254. doi: 10.1038/s41598-020-74399-w [Crossref] [ Google Scholar]
- Mc Ardle R, Del Din S, Galna B, Thomas A, Rochester L. Differentiating dementia disease subtypes with gait analysis: feasibility of wearable sensors?. Gait Posture 2020; 76:372-6. doi: 10.1016/j.gaitpost.2019.12.028 [Crossref] [ Google Scholar]
- Sano Y, Yin Y, Mizuguchi T, Kandori A. Detection of abnormal segments in finger tapping waveform using one-class SVM. In: 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). Berlin, Germany: IEEE; 2019. 10.1109/embc.2019.8856598.
- Yu NY, Chang SH. Characterization of the fine motor problems in patients with cognitive dysfunction - a computerized handwriting analysis. Hum Mov Sci 2019; 65:71-9. doi: 10.1016/j.humov.2018.06.006 [Crossref] [ Google Scholar]
- Fraser KC, Fors KL, Kokkinakis D, Nordlund A. An analysis of eye-movements during reading for the detection of mild cognitive impairment. In: Proceedings of the 2017 Conference on Empirical Methods in Natural Language Processing. Copenhagen, Denmark: Association for Computational Linguistics; 2017. 10.18653/v1/D17-1107.
- Convery R, Mead S, Rohrer JD. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia. Neuropathol Appl Neurobiol 2019; 45(1):6-18. doi: 10.1111/nan.12535 [Crossref] [ Google Scholar]
- Li R, Wang X, Lawler K, Garg S, Bai Q, Alty J. Applications of artificial intelligence to aid detection of dementia: a narrative review on current capabilities and future directions. arXiv [Preprint]. April 29, 2021. https://arxiv.org/abs/2104.14073.
- Brzezicki MA, Kobetić MD, Neumann S, Pennington C. Diagnostic accuracy of frontotemporal dementia An artificial intelligence-powered study of symptoms, imaging and clinical judgement. Adv Med Sci 2019; 64(2):292-302. doi: 10.1016/j.advms.2019.03.002 [Crossref] [ Google Scholar]